Biomarkers on PET, MRI show breast cancer risk
January 23, 2020 -- In a finding they described as "unexpected," researchers used PET and MRI to discover that women with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. Results were published in the January edition of the Journal of Nuclear Medicine.
Discuss
January 23, 2020 -- In a finding they described as "unexpected," researchers used PET and MRI to discover that women with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. Results were published in the January edition of the Journal of Nuclear Medicine.
Discuss Unique PET/CT video shows real-time blood, cardiac motion
January 22, 2020 -- U.S. and Chinese researchers have combined an advanced image reconstruction method with a total-body PET scanner to track real-time blood flow and heart and respiratory function, according to a study published online January 20 in the Proceedings of the National Academy of Sciences.
Discuss
January 22, 2020 -- U.S. and Chinese researchers have combined an advanced image reconstruction method with a total-body PET scanner to track real-time blood flow and heart and respiratory function, according to a study published online January 20 in the Proceedings of the National Academy of Sciences.
Discuss Report: Fujifilm makes pitch for Curium Pharma
January 16, 2020 -- In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as $3 billion, according to a January 14 report from Bloomberg.
Discuss
January 16, 2020 -- In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as $3 billion, according to a January 14 report from Bloomberg.
Discuss Cu-64 DOTATATE PET could handle neuroendocrine tumors
January 15, 2020 -- PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.
Discuss
January 15, 2020 -- PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.
Discuss Flortaucipir-PET shows moderate promise for CTE
January 7, 2020 -- PET imaging with flortaucipir revealed uptake patterns indicative of chronic traumatic encephalopathy (CTE) in a new study published online January 6 in JAMA Neurology, but the tau-binding radiotracer is not quite ready to be declared a reliable biomarker for the condition, the authors noted.
Discuss
January 7, 2020 -- PET imaging with flortaucipir revealed uptake patterns indicative of chronic traumatic encephalopathy (CTE) in a new study published online January 6 in JAMA Neurology, but the tau-binding radiotracer is not quite ready to be declared a reliable biomarker for the condition, the authors noted.
Discuss PET shows tau better predicts brain atrophy than amyloid
January 3, 2020 -- PET scans comparing the location and magnitude of tau protein accumulation have shown that tau better predicts future brain atrophy in patients with Alzheimer's disease compared with amyloid deposition -- and a year or more in advance, according to a study published online January 1 in Science Translational Medicine.
Discuss
January 3, 2020 -- PET scans comparing the location and magnitude of tau protein accumulation have shown that tau better predicts future brain atrophy in patients with Alzheimer's disease compared with amyloid deposition -- and a year or more in advance, according to a study published online January 1 in Science Translational Medicine.
Discuss Zr-89 immuno-PET could help predict cancer therapy outcomes
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss
December 18, 2019 -- Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.
Discuss Can FDG-PET/MRI replace biopsy in breast cancer cases?
December 11, 2019 -- Although FDG-PET/MRI shows promise for accurate staging of breast cancer, the modality still isn't as accurate as sentinel lymph node biopsy, according to a study presented last week at RSNA 2019 in Chicago.
Discuss
December 11, 2019 -- Although FDG-PET/MRI shows promise for accurate staging of breast cancer, the modality still isn't as accurate as sentinel lymph node biopsy, according to a study presented last week at RSNA 2019 in Chicago.
Discuss PET and prejudice: Insurance firms' misconceptions
December 10, 2019 -- Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the Journal of Nuclear Medicine.
Discuss
December 10, 2019 -- Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the Journal of Nuclear Medicine.
Discuss PET rules out need for radiotherapy in lymphoma patients
December 10, 2019 -- Most patients with diffuse large B-cell lymphoma who have a clear PET scan can safely skip radiation treatment, according to a study funded by the U.S. National Cancer Institute that was presented December 8 at the 2019 American Society of Hematology conference in Orlando, FL.
Discuss
December 10, 2019 -- Most patients with diffuse large B-cell lymphoma who have a clear PET scan can safely skip radiation treatment, according to a study funded by the U.S. National Cancer Institute that was presented December 8 at the 2019 American Society of Hematology conference in Orlando, FL.
Discuss
Special Feature
Men greatly outnumber women in academic nuclear medicine
The under-representation of women in academic diagnostic radiology has had a ripple effect in nuclear medicine, where men outnumber women by almost 6-to-1 in professorial and leadership positions in the U.S. and Canada. Read more
Industry News
VENDOR CONNECT
Conferences
PET/CT Imaging 2020
April 24-25
Las Vegas, Nevada United States
April 24-25
Las Vegas, Nevada United States
American Society of Nuclear Cardiology (ASNC) Annual Scientific Session
September 24-27
Washington, District of Columbia United States
September 24-27
Washington, District of Columbia United States